337 related articles for article (PubMed ID: 31852543)
21. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
22. Cell-mediated immune response to human T-lymphotropic virus type I.
Mosley AJ; Asquith B; Bangham CR
Viral Immunol; 2005; 18(2):293-305. PubMed ID: 16035941
[TBL] [Abstract][Full Text] [Related]
23. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
[TBL] [Abstract][Full Text] [Related]
24. How does HTLV-I persist despite a strong cell-mediated immune response?
Asquith B; Bangham CR
Trends Immunol; 2008 Jan; 29(1):4-11. PubMed ID: 18042431
[TBL] [Abstract][Full Text] [Related]
25. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
26. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
27. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
28. HTLV-1 associated myelopathy/tropical spastic paraparesis: how far have we come?
Morgan O
West Indian Med J; 2011 Oct; 60(5):505-12. PubMed ID: 22519224
[No Abstract] [Full Text] [Related]
29. Status of humoral and cellular immune markers in human T-cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers in northeastern Iran, Mashhad.
Hedayati-Moghaddam MR; Mollahosseini F; Namazi MJ; Mosavat A; Rezaee SA; Mahdifar M; Bidkhori HR; Valizadeh N; Rafatpanah H
J Neurovirol; 2020 Dec; 26(6):863-869. PubMed ID: 33025348
[TBL] [Abstract][Full Text] [Related]
30. Human T-cell lymphotropic virus type I and neurological diseases.
Nagai M; Osame M
J Neurovirol; 2003 Apr; 9(2):228-35. PubMed ID: 12707853
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Genetic Diversity of HTLV-1 ORF-I Sequences Collected from Patients with Different Clinical Profiles.
Borba MMN; Farre L; Bittencourt AL; Castro-Amarante MF; Galvão-Castro B; Santos LA; Araújo THA; Alcantara LCJ; Barreto FK
AIDS Res Hum Retroviruses; 2019 Sep; 35(9):881-884. PubMed ID: 31154802
[TBL] [Abstract][Full Text] [Related]
32. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
33. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
34. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
[TBL] [Abstract][Full Text] [Related]
35. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.
Gessain A
J Neurovirol; 1996 Oct; 2(5):299-306. PubMed ID: 8912206
[TBL] [Abstract][Full Text] [Related]
36. HTLV-1-infected thymic epithelial cells convey the virus to CD4
Carvalho Barros LR; Linhares-Lacerda L; Moreira-Ramos K; Ribeiro-Alves M; Machado Motta MC; Bou-Habib DC; Savino W
Immunobiology; 2017 Dec; 222(12):1053-1063. PubMed ID: 28888743
[TBL] [Abstract][Full Text] [Related]
37. The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Suzuki J; Kira J; Baba E; Nakamura M; Koyanagi Y; Nakamura T; Kawano Y; Yamasaki K; Shirabe S; Hatano N; Hayashi K; Yamamoto N; Kobayashi T
J Infect Dis; 1996 May; 173(5):1115-22. PubMed ID: 8627062
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
[TBL] [Abstract][Full Text] [Related]
39. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
[TBL] [Abstract][Full Text] [Related]
40. HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
Martinez MP; Cheng X; Joseph A; Al-Saleem J; Panfil AR; Palettas M; Dirksen WP; Ratner L; Green PL
Retrovirology; 2019 Dec; 16(1):44. PubMed ID: 31864373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
